Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06949605 · ClinicalTrials.gov registry record
Quantitative Xylazine Measurement in ED
A clinical trial of Substance Use Disorders and Opioid Overdose, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 15
- Enrollment target
- 2
- Study locations
NCT06949605: Recruiting study of Substance Use Disorders and Opioid Overdose, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06949605 is a study of Substance Use Disorders and Opioid Overdose that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 15 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06949605, a study of Substance Use Disorders and Opioid Overdose, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)
Primary Outcome
Concentration of Xylazine in blood as determined by lab.
Conditions Studied
Study Locations (2)
New York
- NYC Health + Hospitals/Elmhurst - Elmhurst
- Icahn School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-02-24 |
What NCT06949605 shows while recruiting
NCT06949605 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT06949605 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06949605 about?
NCT06949605 is a clinical study titled "Quantitative Xylazine Measurement in ED". Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)
What is the current status of trial NCT06949605?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-04-01. Estimated completion is 2026-02-24.
What conditions does trial NCT06949605 study?
This clinical trial studies the following conditions: Substance Use Disorders, Opioid Overdose.
Who is sponsoring clinical trial NCT06949605?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06949605 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06949605's enrollment target sits among peer trials
15 89th of 93 higher than 5 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI